Evaluating the status of antibiotic approvals and readiness to combat antimicrobial resistance: What else can we do better?

Drug Discov Today. 2023 Aug;28(8):103674. doi: 10.1016/j.drudis.2023.103674. Epub 2023 Jun 24.

Authors

Charles Oo¹, Xiaoping Zhang², Sherwin K B Sy³

Affiliations

¹ Sunlife Biopharma Consulting, NJ, USA. Electronic address: [email protected].
² XP Pharma Consulting, MA, USA.
³ State University of Maringo, Maringo, Brazil.

PMID: 37356614
DOI: 10.1016/j.drudis.2023.103674

No abstract available

Publication types

Editorial

MeSH terms

Anti-Bacterial Agents* / pharmacology
Anti-Bacterial Agents* / therapeutic use
Drug Resistance, Bacterial*
Microbial Sensitivity Tests

Substances

Anti-Bacterial Agents